Should You Buy GE HealthCare Stock For Its Cash?
Today’s big story: Anthropic IPO: Priced For 2031, Or 2036?
GE HealthCare Technologies (GEHC) stock offers a free cash flow yield of 5.1%, against 4.3% for the median S&P 500 company. A yield above the median usually means one of two things. Either the stock is cheap, or the market expects the business to shrink. So which of the two is GE HealthCare?

GE HealthCare’s Sales Keep Growing
The figures lean toward a cheap stock. GE HealthCare grew revenue 6.9% over the twelve months to September 2026, compared with 3.5% in the twelve months before. Free cash flow reached $1.89 billion over the latest twelve months, up from $1.40 billion a year earlier.
That cash matters to anyone holding the stock. A shareholder has a claim on that cash whether or not it is paid out, just as with profit. Cash kept inside the company still belongs to its owners. Share prices can catch up with that cash once the market notices it. That is more likely when the cash is rising.
GE HealthCare earns its cash by selling imaging systems and the drugs used in scans. Imaging, its largest business, brought in $9.24 billion of revenue in fiscal 2025. Patient Care Solutions made $3.09 billion of sales that year. The scan drugs sit in Pharmaceutical Diagnostics, mostly contrast media. Management says that revenue “is recurring and grows with patient volume.” The company’s operating margin was 13.3% over the latest twelve months, against 18.9% for the S&P 500 as a whole. Capital spending took 21.8% of the cash its operations produced.
Free cash flow has stayed above zero in every twelve-month period since September 2023. But it has not risen every year. The company generated $1.72 billion in the twelve months to September 2023. That was more than it made in the twelve months to September 2025.
Owners also have to weigh the company’s debt. At the end of September 2026, GE HealthCare’s debt, net of cash, equaled 20.5% of its market value. That market value is taken at the November 17 close. Measured against the company’s value including that debt, the free cash flow yield is 4.2%. Operating income covered interest expense 6.6 times over the latest twelve months.
Why You Might Doubt GE HealthCare’s Cash
Most of GE HealthCare’s free cash flow so far in 2026 came in one quarter. The company produced $793 million in the third quarter of fiscal 2026. That compares with $68 million in the second quarter. The third-quarter figure was up from $483 million a year earlier. Management said that rise came from lower tariff payments and refunds, operational profitability and the timing of collections. Refunds and collection timing are not cash a buyer can expect every quarter.
In October, management raised its fiscal 2026 forecasts for sales growth and earnings. It kept its free cash flow guide at more than $1.6 billion. That guide sits above the $1.51 billion GE HealthCare reported for fiscal 2025.
Costs add to the doubt. On the fiscal Q3 2026 call, management said higher costs for memory chips and oil hurt margin. It added that demand from data centers and AI for parts such as memory chips will most likely last for multiple years. GE HealthCare has signed multiyear agreements with several technology partners to secure memory chips. Management says its price and cost actions are starting to deliver a more meaningful benefit.
What To Watch At GE HealthCare In February
The open question for an owner is simple. Will GE HealthCare’s free cash flow keep rising once the third quarter’s refunds and collection timing have passed? The company also has to keep serving its debt while memory chips and oil cost more. GE HealthCare is expected to report its fiscal fourth quarter in February 2027. Management also plans to give its 2027 forecast then. Full-year free cash flow, measured against management’s guide, is the number to watch.
One company’s cash can swing hard from one quarter to the next, as GE HealthCare’s did in 2026. Income drawn from many holdings does not depend on one company. So it tends to come with smaller drops.
More Income. Smaller Drops.
Is your portfolio paying you enough? The Trefis Income Solution holds 50 dividend stocks yielding about 3x the S&P 500, each with at least 10 straight years of dividends. In backtests, it lost less than the S&P 500 in all 9 big selloffs since 2018. Why not choose a better approach?
Spot an error or want more like this? Tell us in 10 seconds.